Summary
An antiserum was produced in rabbits to acute undifferentiated leukemia (AUL) antigens. Partial absorption of the antiserum allowed the removal of the cytotoxic activity against normal mononuclear cells of peripheral blood and bone marrow, in contrast to blast cells from acute and chronic leukemias, which were killed by the antiserum in a standard NIH cytotoxicity test. These observations suggest that antigens present on blast cells of AUL are also expressed on some acute and chronic leukemic cells and that these antigens could be interpreted as B or leukemia-associated antigens because of the disappearance of all cytotoxic activity of the immune serum after extensive absorption with B cells from chronic lymphoid leukemia.
Similar content being viewed by others
References
Abramson C. S., Kersey J. H., LeBein T.: A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage — J. Immunol.126, 83, 1981.
Baker M. A., Falk R. E., Falk J., Greaves M. F.: Detection of monocyte specific antigen of human acute leukaemia cells — Brit. J. Haemat.32, 13, 1976.
Billing R., Rafizadeh B., Drew I.: Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera — J. exp. Med.144, 167, 1976.
Billing R., Ting A., Terasaki P. I.: Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. II. Detection by human anti B-cell alloantisera — J. nat. Cancer Inst.158, 199, 1977.
Blume K. G., Beutler E., Bross K. J., Chillar R. K., Ellingtion U. B., Fahey J. L., Farbstein M. J., Forman S. J., Schmidt G. M., Scott E. P., Spruce W. E., Turner A., Wolf J. L.: Bone marrow ablation and allogeneic marrow transplantation in acute leukemia — New Engl. J. Med.302, 1041, 1980.
Borella L., Sen L.: T and B lymphocytes and lymphoblasts in untreated acute lymphocytic leukemia — Cancer (Philad.)34, 646, 1974.
Borella L., Sen L., Casper J. T.: Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-forming and non-E rosette-forming ALL blasts — J. Immunol.118, 309, 1977.
Bøyum A.: Separation of leucocytes from blood and bone marrow — Scand. J. clin. Lab. Invest.21 (Suppl. 97), 1, 1968.
Brown G., Hogg N., Greaves M.: Candidate leukemia specific antigen in man — Nature (Lond.)258, 454, 1975.
Clarkson B. D.: Acute myelocytic leukemia in adults — Cancer (Philad.)30, 1572, 1972.
Delfini C., Nesci S., De Biagi M., Polchi P., Valentini M., Lucarelli G.: Cytochemical and immunological properties of cryopreserved blast cells — Haematologica (Pavia)66, 151, 1981.
Dicke K. A., McCredie K. B., Spitzer G., Zander A., Peters L., Verma D. S., Steward D., Keating M., Stevens E. E.: Autologous bone marrow transplantation in patients with acute leukemia in relapse — Transplantation26, 169, 1978.
Greaves M. F., Brown G., Rapson N., Lister A.: Antisera to human leukemic cells — Clin. Immunol. Immunopath.4, 67, 1975.
Köhler G., Milstein C.: Continuous cultures of fused cells secreting antibody of predefined specificity — Nature (Lond.)256, 495, 1975.
LeBein T., Hurwitz R., Kersey J.: Characterization of a xeno-antiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line — J. Immunol.122, 82, 1979.
Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I.: Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte cytotoxicity test — Transplantation6, 913, 1968.
Nadler L., Ritz J., Hardy R., Pesando J. M., Schlossman S. F.: A unique cell surface antigen identifying lymphoid malignancies of B cell origin — J. clin. Invest.67, 134, 1981.
Netzel B., Rodt H., Haas R. J., Kolb H. J., Thierfelder S.: Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukemia — Lanceti, 1330, 1980.
Ritz J., Pesando J. M., McConarty J., Lazerus H., Schlossman S. F.: A monoclonal antibody to human acute lymphoblastic leukemia antigen — Nature (Lond.)283, 583, 1980.
Robinson J., Sieff C., Delia D., Edwards P. A., Greaves M.: Expression of cell surface DR, HLA, ABC and glycophorin during erythroid differentiation — Nature (Lond.)289, 68, 1981.
Shumak K. H., Baker M. A., Taub R. N., Coleman M. S. and The Toronto Leukemia Study Group: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis — Cancer Res.40, 4048, 1980.
Thomas E. D., Buckner C. D., Banaji M., Clift R. A., Fefer A., Flournoy N., Goodell B. W., Hickman R. O., Lerner K. G., Neiman P. E., Sale G. E., Sanders J. E., Singer J. W., Steven M., Storb R., Weiden P. L.: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation — Blood49, 511, 1977.
Thomas E. D., Buckner C. D., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Sale G. E., Sanders J. E., Singer J. W., Shulman H., Storb R., Weiden P. L.: Marrow transplantation for acute non-lymphoblastic leukemia in first remission — New Engl. J. Med.301, 597, 1979.
Trucco M. M., Stoker J. W., Ceppellini R.: Monoclonal antibodies against human lymphocyte antigens — Nature (Lond.)273, 666, 1978.
Author information
Authors and Affiliations
Additional information
Supported by grant no. 8001963.96 from theConsiglio Nazionale delle Ricerche (CNR), Roma, Italy andStiftung Volkswagenwerk, Bundesrepublik Deutschland.
Rights and permissions
About this article
Cite this article
Delfini, C., De Biagi, M., Nesci, S. et al. An attempt to obtain a specific antiserum forin vitro immunological conditioning of bone marrow in acute non-lymphoblastic leukemia. La Ricerca Clin. Lab. 11, 239–245 (1981). https://doi.org/10.1007/BF02890530
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02890530